Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Equillium Inc EQ

Healthcare Biotechnology
Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Company’s pipeline consists of immunomodulatory assets and a product platform targeting immuno-inflammatory pathways. The Company’s EQ101 is a selective tri-specific cytokine inhibitor targeting IL-2, IL... see more

Recent & Breaking News (NDAQ:EQ)

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire April 3, 2024

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Business Wire April 1, 2024

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Business Wire March 25, 2024

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference

Business Wire March 22, 2024

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Business Wire December 21, 2023

EQ Bank Card launches in Québec as Carte Banque EQ

PR Newswire November 20, 2023

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Business Wire November 13, 2023

Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Business Wire November 8, 2023

Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology

Business Wire November 6, 2023

Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology

Business Wire October 19, 2023

Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium

Business Wire October 16, 2023

Equillium to Host Analyst & Investor Day

Business Wire October 3, 2023

Equillium to Present at the JonesTrading 2023 Healthcare Summit

Business Wire October 2, 2023

Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences

Business Wire September 20, 2023

Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference

Business Wire August 30, 2023

Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Business Wire August 9, 2023

Equillium Announces $7.5 Million Share Repurchase Program

Business Wire August 2, 2023

Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences

Business Wire June 1, 2023

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists

Business Wire May 15, 2023

Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates

Business Wire May 11, 2023